乳腺细胞:瘤细胞增殖的一个新发现的驱动因素
Katelyn Del Toro1, Yamhilette Licon-Munoz1, William Crabtree1
1Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, 1 University of New Mexico MSC08 4670, Albuquerque, NM, United States.
Frontiers in oncology
|January 1, 2025
概括
由于未知的微环境因素,乳腺癌的治疗具有挑战性. 新的研究确定了周围血管细胞是瘤生长的关键驱动因素,提供了潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症 微环境 研究 研究
背景情况:
- 由于对瘤微环境的理解有限,乳腺癌治疗面临挑战.
- 组织居住的周血管细胞对血管健康至关重要,但在癌症中尚未得到充分研究.
- 鉴定和分离周围血管细胞是很困难的,因为稀少,异质,和共享的标志物.
研究的目的:
- 为了识别和描述乳腺瘤微环境中的周围细胞.
- 研究周血管细胞在乳腺癌进展和患者死亡率中的作用.
- 为生物研究开发净化和建模周血管细胞的方法.
主要方法:
- 利用光激活细胞分类 (FACS) 来识别和净化乳腺组织中不同的细胞类型.
- 在纯化的细胞类型上进行深度序列转录,包括细胞周细胞.
- 采用单细胞RNA测序来定义乳腺细胞的异质性和识别可视化标记物.
主要成果:
- 研究人员发现,围细胞特异性基因与乳腺癌患者死亡率之间存在强烈的关联.
- 观察到周血管细胞与血管分离,并在瘤的一个子集中成为占主导地位的介质细胞类型.
- 与纤维细胞相比,培养的细胞细胞显著增强了乳腺瘤细胞的生长.
结论:
- 周血管细胞被认为是乳腺癌中关键的微环境因素.
- 需要对周围血管细胞生物学进行进一步的研究,以发现治疗点.
- 向周围血管细胞介导刺激机制可能为乳腺癌提供新的治疗策略.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer
47.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.8K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K


